EV/EBITDA - Fisher & Paykel Healthcare Corporation Ltd (ASX:FPH) - Alpha Spread
F

Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
Watchlist
Price: 34.72 AUD -1.03% Market Closed
Market Cap: 20.3B AUD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

62.7
Current
39
Median
12.5
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
62.7
=
Enterprise Value
20.3B AUD
/
EBITDA
353.4m NZD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
37.8
2-Years Forward
EV/EBITDA
32.3
3-Years Forward
EV/EBITDA
27.6

See Also

Discover More